CODA Biotherapeutics

company

About

CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$670K
Industries
Biotechnology,Genetics,Medical,Therapeutics
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity. With chemogenetics, target neuronal populations are modified using gene therapy to express a tunable ligand-gated ion channel. These ligand-gated ion channels are engineered to be highly responsive to a specific proprietary small molecule but are otherwise inactive. The interaction of the small molecule and engineered receptor allows for exquisite, dose-dependent control of the neurons to generate the therapeutic effect.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$62.67M
CODA Biotherapeutics has raised a total of $62.67M in funding over 2 rounds. Their latest funding was raised on Dec 2, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 2, 2021 Series Unknown $28M 1 Detail
Nov 10, 2020 Grant $670K 1 Detail
Nov 5, 2019 Series A $15M 1 Versant Ventures Detail
Sep 12, 2018 Series A $19M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
2
2
CODA Biotherapeutics is funded by 2 investors. Versant Ventures and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series Unknown
National Institutes of Health Grant